Numerous UT MD Anderson Meet the Experts sessions are scheduled throughout ESMO.
Friday, October 23 (All times in CEST)
11:00每11:30 (11每11:30 a.m.)
The new era of KRAS-directed therapy
Assistant Professor, Thoracic/Head and Neck Medical Oncology
13:30每14:00 (1:30每2 p.m.)
Defining the future of breast cancer care, Part 1
Professor, Breast Medical Oncology
16:00每17:00 (4每5 p.m.)
The next generation of immunotherapies, Part 1
Associate Professor, Investigational Cancer Therapeutics
Saturday, October 24 (All times in CEST)
10:30每11:00 (10:30每11 a.m.)
Shaping tomorrow's gynecologic cancer care
Professor, Gynecologic Oncology and Reproductive Medicine
Professor, Gynecologic Oncology and Reproductive Medicine
10:30每11:00 (10:30每11 a.m.)
The next generation of immunotherapies, Part 2
Professor, Melanoma Medical Oncology
Professor, Investigational Cancer Therapeutics
Executive Director, Immuno-Oncology Clinical Drug Development Program
11:00每11:30 (11每11:30 a.m.)
New horizons in head and neck cancer care
Professor, Head and Neck Medical Oncology
Professor, Head and Neck Surgery
Assistant Professor, Head and Neck Medical Oncology
11:00每12:00 (11 a.m.每12 p.m.)
Patient-centered palliative care
Professor, Palliative Care and Rehabilitation Medicine
11:30每12:00 (11:30每12 p.m.)
Decoding the latest leukemia advances, Part 1
Professor, Leukemia
13:00每13:30 (1每1:30 p.m.)
Clinical trials at UT MD Anderson
Chief Clinical Research Officer
13:00每13:30 (1每1:30 p.m.)
Defining the future of breast cancer care, Part 2
Chair and Professor, Breast Medical Oncology
Sunday, October 25 (All times in CET)
10:15每10:45 (10:15每10:45 a.m.)
Transforming outcomes in genitourinary cancers
Associate Professor, Genitourinary Medical Oncology
Assistant Professor, Genitourinary Medical Oncology
Assistant Professor, Genitourinary Medical Oncology
11:00每11:30 (11每11:30 a.m.)
Accelerating discoveries with industry partnerships
Emily Barnhill
Vice President, Strategic Industry Ventures
11:30每12:00 (11:30每12 p.m.)
Hereditary cancer in the era of precision oncology, Part 1
Professor, Breast Medical Oncology
Professor, Clinical Cancer Prevention
13:00每13:30 (1每1:30 p.m.)
From target to therapy: Advances in drug discovery
Tim Heffernan, Ph.D.
Vice President and Head of R&D, Therapeutics Discovery
Vice President, Head of Clinical Development, Therapeutics Discovery Division
Professor, Department of Investigational Cancer Therapeutics
14:00每14:30 (2每2:30 p.m.)
The expansion of antibody drug conjugates
Professor, Genitourinary Medical Oncology
Professor, Investigational Cancer Therapeutics
17:00每17:30 (5每5:30 p.m.)
Hereditary cancer in the era of precision oncology, Part 2
Professor and Chair Ad Interim, Clinical Cancer Prevention
Professor, Gastrointestinal Medical Oncology
Assistant Professor, Gynecologic Oncology and Reproductive Medicine
Monday, October 26 (All times in CET)
10:00每11:00 (10每11 a.m.)
The next generation of immunotherapies, Part 3
Associate Professor, Investigational Cancer Therapeutics
11:30每12:00 (11:30每12 p.m.)
Decoding the latest leukemia advances, Part 2
Associate Professor, Leukemia
12:00每12:30 (12每12:30 p.m.)
Translating genomic discovery into clinical impact
Chair, Genomic Medicine
Professor, Investigational Cancer Therapeutics